Department of Cardiology, National Clinical Research Center of Geriatric Disease, Chinese PLA General Hospital, Beijing, China; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Department of Geriatric Cardiology, National Clinical Research Center of Geriatric Disease, Chinese PLA General Hospital, Beijing, China.
Biochim Biophys Acta Mol Basis Dis. 2019 Jul 1;1865(7):1822-1830. doi: 10.1016/j.bbadis.2018.06.011. Epub 2018 Jun 23.
Cellular senescence is the permanent cell cycle arrest induced either by chronological ageing or extrinsic stimuli. Recent researches have identified cellular senescence as an important mechanism for atherosclerosis, which is the essential pathophysiological contributor to cardiovascular diseases (CVDs). The sirtuins are a family of cellular deacetylases with fundamental abilities to regulate cellular metabolism and a variety of physiological activities. Previous studies have revealed the anti-ageing functions of sirtuins as the longevity-associated proteins. These advances indicate the potential beneficial functions of sirtuins in atherosclerosis by affecting cellular senescence. Herein, we review the recent findings about sirtuins in regulating atherosclerotic cellular senescence, and discuss the possibility of activating sirtuins as a therapeutic strategy for combating atherosclerosis.
细胞衰老(Cellular senescence)是由衰老或外在刺激引起的永久性细胞周期停滞。最近的研究已经确定细胞衰老(Cellular senescence)是动脉粥样硬化(atherosclerosis)的一个重要机制,而动脉粥样硬化(atherosclerosis)是心血管疾病(cardiovascular diseases)的重要病理生理学诱因。沉默调节蛋白(sirtuins)是一类细胞去乙酰化酶家族,具有调节细胞代谢和多种生理活动的基本能力。先前的研究揭示了沉默调节蛋白(sirtuins)作为长寿相关蛋白的抗衰老功能。这些进展表明,沉默调节蛋白(sirtuins)通过影响细胞衰老(cellular senescence),在动脉粥样硬化(atherosclerosis)中具有潜在的有益功能。在此,我们综述了沉默调节蛋白(sirtuins)在调节动脉粥样硬化细胞衰老(atherosclerotic cellular senescence)方面的最新发现,并讨论了激活沉默调节蛋白(sirtuins)作为对抗动脉粥样硬化(atherosclerosis)的治疗策略的可能性。